GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$46.86 USD
-0.08 (-0.17%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $46.85 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
For GSK PLC Sponsored ADR, the company has a dividend yield of 3.60% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GSK 46.86 -0.08(-0.17%)
Will GSK be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for GSK based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for GSK
GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow
GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View
GSK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
GSK (GSK) Q3 Earnings and Revenues Beat Estimates
Here's Why GSK (GSK) is a Strong Growth Stock
Other News for GSK
GSK forms Narrow Range Bar on October 31
New 52 Week Closing High appears for GSK after 2.2% move
GSK Advances Share Buyback Program with Recent Purchase
Barclays Keeps Their Hold Rating on GlaxoSmithKline (GSK)
GSK Executives Sell Significant Shares on London Stock Exchange